DeviceClearance

Apollo ESG NXT System, Apollo REVISE NXT System— 510(k) K232544

Substantially Equivalent

Apollo Endosurgery, Inc.

FDA 510(k) clearance K232544 for Apollo ESG NXT System, Apollo REVISE NXT System, Substantially Equivalent on 2023-09-18. Applicant: Apollo Endosurgery, Inc..

Clearance details

Applicant
Apollo Endosurgery, Inc.
Product code
Code QTD
Advisory panel
Gastroenterology, Urology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Austin, TX, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.